Cytarabine 20 mg/ml Solution for Injection/Infusion

DRUG2 trials

Sponsors

Prinses Maxima Centrum voor Kinderoncologie B.V., St. Anna Childrens Cancer Research Institute GmbH

Conditions

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaLangerhans Cell HistiocytosisMixed Phenotype Acute Leukemia

Phase 1

A Phase 1 Trial of the Menin Inhibitor Ziftomenib in Combination with Chemotherapy for Children with Relapsed/Refractory KMT2A-rearranged, NUP98-rearranged, or NPM1-mutant Acute Leukemia

RecruitingCTIS2023-505262-28-00

Prinses Maxima Centrum voor Kinderoncologie B.V.Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia

Start: 2025-03-24Target: 10Updated: 2024-12-02

Phase 2

LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis

Not yet recruitingCTIS2024-512676-36-00

St. Anna Childrens Cancer Research Institute GmbHLangerhans Cell Histiocytosis

Target: 1124Updated: 2024-10-14